Flourish Research News

Flourish Research announces the acquisition of Suncoast Research Group, adding to the rapidly expanding Flourish enterprise. Suncoast, which is in the Little Havana community of Miami, FL is a large, multi-therapeutic site aligned with Flourish’s core therapeutic areas of Cardiology/Metabolic, CNS and Vaccines. Read the full release.

Chris Duignan, who has been named Chief Financial Officer of Flourish Research, will build the financial infrastructure, lead financial operations, and integrate the acquisitions of the rapidly growing organization. Read the full release.

Flourish Research announces the acquisition of Keystone Clinical Studies, adding to the rapidly expanding Flourish enterprise. Keystone, which is in the greater Philadelphia area, is a leader in Alzheimer’s Disease and other CNS research and the addition of the site expands Flourish’s reach in these core areas of research. Read the full release.

Reinhold Schulz has been named Chief Executive Officer of Flourish Research, a company designed to acquire, operate, and integrate the best clinical research sites in North America. Flourish operates large, best-in-class sites with experience in Phases I-IV and investigators with deep expertise in key therapeutic areas. Read the full release.